LogicBio Therapeutics (LOGC) News Today → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free LOGC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsInsider TradesOptions ChainSocial MediaSustainabilityStock AnalysisCompetitorsInsider TradesOptions ChainSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14, 2024 | finance.yahoo.comLogicBio Therapeutics, Inc. (LOGC)March 27, 2024 | seekingalpha.comRVVTF Revive Therapeutics Ltd.September 24, 2023 | finance.yahoo.comLogicBio's IPO: What You Need To KnowMarch 31, 2023 | uk.finance.yahoo.comRare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain Reports LtdNovember 16, 2022 | finance.yahoo.comAlexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® TherapeuticsNovember 16, 2022 | marketbeat.comTrading was temporarily halted for "LOGC" at 07:11 PM with a stated reason of "News pending."November 14, 2022 | finanznachrichten.deLogicBio Therapeutics, Inc.: LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNovember 14, 2022 | finance.yahoo.comLogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNovember 7, 2022 | benzinga.comShort Volatility Alert: LogicBio Therapeutics, Inc.October 17, 2022 | marketwatch.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOGC, IMRA, SBTXOctober 4, 2022 | benzinga.comINVESTOR ALERT: The M&A Class Action Firm Announces the Investigation of LogicBio Therapeutics, Inc. - LOGCOctober 3, 2022 | msn.comLooking Into LogicBio Therapeutics's Recent Short InterestOctober 3, 2022 | marketwatch.comLogicBio Therapeutics Shares Soar on Takeover by AstraZeneca >LOGCOctober 3, 2022 | bizjournals.comAstraZeneca acquires local startup at 660% premiumOctober 3, 2022 | finance.yahoo.comLogicBio's stock skyrockets after buyout bid for a 667% premiumOctober 3, 2022 | msn.comAstraZeneca pays 660% premium for gene therapy firm LogicBioOctober 3, 2022 | nasdaq.comLogicBio To Be Bought By Alexion, AstraZeneca Rare DiseaseOctober 3, 2022 | marketwatch.comAstraZeneca to Buy LogicBio Therapeutics for $68 Million >LOGCOctober 3, 2022 | msn.comWhy LogicBio Therapeutics Stock Is Soaring TodayOctober 3, 2022 | finance.yahoo.comAlexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic MedicineSeptember 21, 2022 | finance.yahoo.comLogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONESeptember 1, 2022 | reuters.comLogicBio Therapeutics IncAugust 18, 2022 | finance.yahoo.comEarnings Update: LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Just Reported And Analysts Are Boosting Their EstimatesAugust 16, 2022 | benzinga.comRecap: LogicBio Therapeutics Q2 EarningsJuly 27, 2022 | finance.yahoo.comLogicBio Therapeutics (LOGC) Moves to Buy: Rationale Behind the UpgradeJune 14, 2022 | morningstar.comLogicBio Therapeutics Inc - Stock Quote LOGCMay 17, 2022 | finance.yahoo.comLogicBio® Therapeutics to Present at H.C. Wainwright Global Investment ConferenceMay 16, 2022 | finance.yahoo.comLogicBio Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Business UpdatesMay 11, 2022 | finance.yahoo.comLogicBio Therapeutics Announces Upcoming Presentations on GeneRide Development Candidate and Multiple Advancements in AAV Manufacturing Processes at ASGCT Annual MeetingMay 9, 2022 | uk.investing.comWhy LogicBio Therapeutics Shares Are Popping Off TodayMay 9, 2022 | markets.businessinsider.comLogicBio Says FDA Lifts Clinical Hold On LB-001 INDMay 9, 2022 | markets.businessinsider.comClinical Development Update from Portfolio Company LogicBioMay 9, 2022 | seekingalpha.comLogicBio surges as FDA lifts clinical hold on lead assetMay 9, 2022 | finance.yahoo.comLogicBio Therapeutics Announces FDA Lifts Clinical Hold on SUNRISE Trial in Pediatric Patients with Methylmalonic AcidemiaMay 9, 2022 | finance.yahoo.comLogicBio Therapeutics Shares Skyrocket As FDA Lifts Clinical Hold On Its Pediatric TrialApril 27, 2022 | msn.comU.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.38%March 23, 2022 | finance.yahoo.comLogicBio Therapeutics to Present at H.C. Wainwright Gene Therapy and Gene Editing ConferenceMarch 12, 2022 | benzinga.comLogicBio Therapeutics's Return On Capital Employed InsightsMarch 8, 2022 | finance.yahoo.comLogicBio Therapeutics to Present at Barclays Global Healthcare ConferenceMarch 4, 2022 | finance.yahoo.comLogicBio Therapeutics Reports Full Year 2021 Financial Results and Provides Business UpdatesMarch 1, 2022 | finance.yahoo.comAgenus (AGEN) Reports Q4 Loss, Lags Revenue EstimatesFebruary 25, 2022 | finance.yahoo.comUniQure (QURE) Tops Q4 Earnings and Revenue EstimatesFebruary 3, 2022 | seekingalpha.comLogicBio downgraded at William Blair citing lack of clarity on catalysts after clinical holdFebruary 2, 2022 | markets.businessinsider.comAnalyst Ratings For LogicBio TherapeuticsFebruary 2, 2022 | finance.yahoo.comWhy Did LogicBio Therapeutics Shares Plunge To 52-Week Low Today?February 2, 2022 | finance.yahoo.comGene-editing company shares drop by one-third after clinical holdFebruary 2, 2022 | finanznachrichten.deArix Bioscience PLC: Clinical development update from portfolio company LogicBioFebruary 2, 2022 | marketwatch.comLogicBio Shares Plummet as FDA Puts Lead Program on Hold >LOGCFebruary 2, 2022 | marketwatch.comLogicBio Therapeutics' Clinical Trial Placed on FDA HoldFebruary 2, 2022 | nasdaq.comLogicBio Therapeutics' Phase 1/2 SUNRISE Trial Of LB-001 Placed On Clinical Hold Get LogicBio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter. Email Address Next President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump. Click here to see why it will be ______ _________. LOGC Media Mentions By Week LOGC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LOGC News Sentiment▼0.000.52▲Average Retail/Wholesale News Sentiment LOGC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LOGC Articles This Week▼20▲LOGC Articles Average Week Get LogicBio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Genfit News Compugen News Adverum Biotechnologies News Elevation Oncology News Cellectis News X4 Pharmaceuticals News Fennec Pharmaceuticals News Kodiak Sciences News Century Therapeutics News Cardiff Oncology News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LOGC) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist My Default Watchlist Adding LogicBio Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
